10 Best Logistics Stocks To Watch Right Now

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, express delivery gorilla FedEx (NYSE: FDX  ) has earned a respected four-star ranking.

With that in mind, let's take a closer look at FedEx, and see what CAPS investors are saying about the stock right now.

FedEx facts

�

�

Headquarters (founded)

Memphis, Tenn. (1971)

Market Cap

$31.7 billion

Industry

Air freight and logistics

Trailing-12-Month Revenue

Hot Industrial Conglomerate Stocks To Buy Right Now: Impax Laboratories Inc.(IPXL)

Impax Laboratories, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and marketing of bioequivalent pharmaceutical products. The company operates in two divisions, Global Pharmaceuticals and Impax Pharmaceuticals. The Global Pharmaceuticals division develops, manufactures, sells, and distributes generic pharmaceutical products. It provides its generic pharmaceutical prescription products directly to wholesalers and retail drug chains; and generic pharmaceutical over-the-counter and prescription products through unrelated third-party pharmaceutical entities. The Impax Pharmaceutical division develops proprietary brand pharmaceutical products that address central nervous system disorders, including Alzheimer?s disease, attention deficit hyperactivity disorder, depression, epilepsy, migraines, multiple sclerosis, Parkinson?s disease, and schizophrenia, as well as promotes third-party branded pharmaceutical products. As of May 2, 2011, the com pany marketed 101 generic pharmaceuticals, which represent dosage variations of 29 different pharmaceutical compounds; and another 16 of its generic pharmaceuticals representing dosage variations of 4 different pharmaceutical compounds. It markets and sells its generic pharmaceutical prescription drug products in the continental United States and the Commonwealth of Puerto Rico. The company has a strategic alliance agreement with Teva Pharmaceuticals Curacao N.V. Impax Laboratories, Inc. was founded in 1993 and is headquartered in Hayward, California.

Advisors' Opinion:

• [By Max Macaluso, Ph.D.]

  RLS hasn't been a high-priority target for the pharma industry given the lackluster sales of Requip and Horizant, a third competitor of�UCB's Neupro, and a number of generic alternatives. Impax Laboratories (NASDAQ: IPXL  ) was one of the few developing a new therapy, called IPX159, but Impax put the kibosh on the drug after it failed to meet its primary endpoint in a phase 2b study. According to its latest quarterly report, Impax has no other RLS drugs in development and seems to be focusing on getting its rejected Parkinson's disease drug Rytary back to the FDA for a second chance at approval.

10 Best Logistics Stocks To Watch Right Now: Portola Pharmaceuticals Inc (PTLA)

Portola Pharmaceuticals, Inc. (Portola), incorporated on September 2, 2003, is a biopharmaceutical company developing product candidates that have the potential to represent advances in the fields of thrombosis and hematology. The Company is advancing its three wholly owned programs using biomarker and genetic approaches.

Betrixaban

Portola's compound, betrixaban, is an oral, once-daily Factor Xa inhibitor being evaluated in the only biomarker-based Phase-III study for hospital to home prophylaxis of venous thromboembolism (VTE) in acute medically ill patients. Betrixaban's properties particularly suited to potentially demonstrate efficacy without increasing bleeding in this patient population.

Andexanet Alfa

Portola's second development candidate, andexanet alfa (PRT4445), has the potential to be a reversal agent to directly reverse the effects of Factor Xa inhibitors in patients who suffer a bleeding episode or who require emergency surgery. Portola has entered into clinical collaboration agreements with all of the manufacturers of direct Factor Xa inhibitors, including Bristol-Myers Squibb and Pfizer (Eliquis [apixaban]), Bayer HealthCare and Janssen Pharmaceuticals (XARELTO [rivaroxaban]), and Daiichi Sankyo (Savaysa [edoxaban]), while retaining all decision-making and commercial rights to the program.

Cerdulatinib (PRT2070) and PRT2607

Portola's third wholly owned product candidate, cerdulatinib (PRT2070), is an orally available kinase inhibitor that uniquely inhibits two validated tumor proliferation pathways - spleen tyrosine kinase (Syk) and janus kinase (JAK). It is being studied in patients with leukemias or lymphomas with a focus on genetically-defined subtypes, as well as in patients who have failed therapy due to relapse or acquired mutations. Portola's fourth program is partnered with Biogen Idec and is focused on the development of PRT2607, a selective Syk inhibitor.

Advisors' Opinion:

• [By Todd Campbell]

  That leads me to Medivation (NASDAQ: MDVN  ) , Ophthotech (NASDAQ: OPHT  ) , and Portola (NASDAQ: PTLA  ) , three companies with important therapies that may very well be destined to become top sellers.

10 Best Logistics Stocks To Watch Right Now: Sonoco Products Company(SON)

Sonoco Products Company provides industrial and consumer packaging products, and packaging services worldwide. It offers composite paperboard cans; paperboard packages; fiber cartridges; layered bottles and jars; laminated tubs, cups, and spools; consumer and institutional trays; and aluminum, steel, and peelable membrane easy-open closures, as well as flexible packaging, product design, tool design, fabrication, and manufacturing services. The company also produces paperboard tubes, cores, roll packaging, molded plugs, pallets, pallet components, concrete forms, rotary die boards, recycled paperboard, chipboard, tube board, lightweight corestock, boxboard, linerboard, corrugating medium, specialty grades, and recovered paper products; and steel, nailed wooden, plywood, recycled, and polyfiber reels, as well as recycles old corrugated container, paper, plastic, metal, and glass materials. In addition, it manufactures custom-printed glass covers and coasters; offers custom packing, fulfillment, and primary package filling services, as well as operates scalable service centers; contract packaging, co-packing, and fulfillment services; and temporary, semipermanent, and permanent point-of-purchase displays. Further, the company provides fabricated foam, corrugated paperboard, molded EPS and EPP, antistatic fabricated foam solutions, nesting and stacking trays, molded foam dunnage, totes and tote inserts, energy-absorbing and flotation components, and insulation components, as well as contract package testing service. Additionally, it offers insulated shippers, durable transport chests, gel packs, phase change materials, lab/pharma/diagnostic specimen transport, refrigerant materials, edge and corner protection, and temperature assurance solutions; high-visibility packaging and printed products; and blister packaging machines. The company, formerly known as Southern Novelty Company, was founded in 1899 and is based in Hartsville, South Carolina. Advisors' Opinion:

• [By Marc Bastow]

  Industrial and consumer packaging products manufacturer Sonoco (SON) raised its quarterly dividend 3.22% to 32 cents per share.
  Payout Date: June 10
  Ex-Dividend Date: May 14
  SON Dividend Yield: 3.04%

• [By David Fish]

  Once known as the Southern Novelty Company, Sonoco Products (SON) is a leading producer of paper-based tubes and cores, flexible packaging, rigid plastic containers, cylinder paperboard, wire and cable reels, and point-of-purchase displays.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Sonoco Products (NYSE: SON  ) , whose recent revenue and earnings are plotted below.

• [By Seth Jayson]

  Sonoco Products (NYSE: SON  ) reported earnings on July 18. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended June 30 (Q2), Sonoco Products met expectations on revenues and beat slightly on earnings per share.

10 Best Logistics Stocks To Watch Right Now: Wizard World Inc (WIZD)

Wizard World, Inc., incorporated on May 2, 2001, produces pop culture and live multimedia conventions (Comic Cons) across North America that provide a social networking and entertainment venue for fiction enthusiasts of movies, television shows, video games, technology, toys, social networking/gaming platforms, comic books and graphic novels. The Company has two lines of business: live multimedia events, which involves ticket sales and exhibitor booth space, and sponsorships and advertising. On December 7, 2010, the Company acquired Conventions (which collectively refers to Kick The Can Corp. and its predecessors Wizard Conventions, Inc. and Kicking The Can, L.L.C) pursuant to a Share Purchase and Share Exchange Agreement (the Exchange Agreement). As the result of the Share Exchange, Conventions became a wholly owned subsidiary of the Company. The Company, through, Conventions, is a producer of pop culture and live multimedia conventions. On November 13, 2010, the Company acquired the production rights to the Mid-Ohio Comic Con from GCX Holdings.

These Comic Cons provide entertainment companies, toy companies, gaming companies, publishing companies and retailers venues for their sales, marketing, promotions, public relations, advertising and sponsorships efforts. On March 18, 2011, the Company formed a wholly owned subsidiary, Wizard World Digital, Inc. (Digital). Among other things, Digital monitors and sends emails to its fan database; manages its Website www.wizardworld.com and its online accounts, and produces the Company�� online newsletter, Wizard World Digital. The Company also produces Wizard World Digital, an online publication covering new and upcoming products and talents in the pop culture world, which is distributed on a weekly basis to online and iPad users worldwide. Kick The Can Corp. was incorporated in Nevada on September 20, 2010. As of November 17, 2011, the Conventions held the production rights to 11 conventions: Atlanta Comic Con (Atlanta, GA); Big Apple Comic Co! n (New York, NY); Cincinnati Comic Con (Cincinnati, OH); Connecticut Comic Con (Hartford, CT); Nashville Comic Con (Nashville, TN); New England Comic Con (Boston, MA); North Coast Comic Con (Akron, OH); Toronto Comic Con (Toronto, Ontario); Nola Comic Con (New Orleans, LA); Central Canada Comic Con (Winnipeg, Manitoba), and Mid-Ohio Comic Con (Columbus, OH). The Company developed the Comic Cons in Miami, FL, Anaheim, CA, Austin, TX, Philadelphia, PA and Chicago, IL.

The Company competes with Reed Exhibitions Limited and Hobby Star Marketing Inc.

Advisors' Opinion:

• [By CRWE]

  Today, WIZD remains (0.00%) +0.000 at $.520 thus far (ref. google finance June 20, 2013).

  Wizard World, Inc. previously reported record financial results for the quarter ended March 31, 2013 today.

  Convention revenue was $1,793,476 for the three months ended March 31, 2013, as compared to $520,155 for the comparable period ended March 31, 2012, an increase of $1,273,321. The Company produced two events during the period ended March 31, 2013, as compared to one event during the comparable period ended March 31, 2012. Average revenue generated per event in 2013 was $896,737 as compared to $520,155 during 2012.

10 Best Logistics Stocks To Watch Right Now: Jacksonville Bancorp Inc. (JXSB)

Jacksonville Bancorp, Inc. operates as the holding company for Jacksonville Savings Bank that provides various banking products and services in Illinois. Its deposit products include interest-bearing and non interest-bearing checking accounts, savings accounts, money market accounts, term certificate accounts, individual retirement accounts, and certificates of deposit. The company?s loan portfolio comprises one-to four-family mortgage loans; commercial and agricultural real estate, and multi-family residential real estate loans; commercial and agricultural business loans; and consumer loans, such as home equity loans and lines of credit, and automobile loans. It operates through its main office, as well as through six branches located in Jacksonville, Virden, Litchfield, Chapin, and Concord, Illinois. The company was founded in 1916 and is based in Jacksonville, Illinois. Jacksonville Bancorp, Inc. is a subsidiary of Jacksonville Bancorp, MHC.

Advisors' Opinion:

• [By Traders Reserve]

  Jacksonville Bancorp (JXSB), based in Illinois, owns a loan portfolio comprised of one-to four-family residential real estate; commercial and agricultural real estate; multi-family residential real estate loans; commercial and agricultural business loans; home equity loans and lines of credit.

10 Best Logistics Stocks To Watch Right Now: Teucrium Wheat Fund (WEAT)

Teucrium Wheat Fund (the Fund) is a commodity pool. The Fund is a series of the Teucrium Commodity Trust (Trust). The Fund provides investors unleveraged direct exposure to wheat without the need for a futures account. The investment objective of the Fund is to have the daily changes in percentage terms of a weighted average of the closing settlement prices for three futures contracts for wheat (Wheat Futures Contracts) that are traded on the Chicago Board of Trade (CBOT), which includes the second-to-expire CBOT Wheat Futures Contract, weighted 35%; the third-to-expire CBOT Wheat Futures Contract, weighted 30%, and the CBOT Wheat Futures Contract, weighted 35%. The Fund is managed by Teucrium Trading, LLC. Advisors' Opinion:

• [By Paul Ausick]

  The Teucrium Wheat Fund (NYSEMKT: WEAT) closed down 2.43% on Friday to finish the week at $16.47. For the week the fund was up 0.8%. The 52-week range is $13.31 to $19.50. Like corn, the price is up more than 12% since the beginning of the year and down 10.5% over the past 12 months. This fund trades averages just 41,000 shares traded in a day, but nearly tripled that on Friday, when wheat prices fell more than 2% on the CBOT to close at $6.955 a bushel.

10 Best Logistics Stocks To Watch Right Now: Incyte Corporation(INCY)

Incyte Corporation focuses on the discovery and development of proprietary small molecule drugs for hematologic and oncology indications, and inflammatory and autoimmune diseases. Its product pipe line includes INCB18424, which is in Phase III clinical trial for myelofibrosis; Phase III trial for polycythemia vera; Phase III trial for essential thrombocythemia; Phase I/II trial to treat solid tumors/other hematologic malignancies; and Phase IIb trail for the treatment of psoriasis. The company?s portfolio also includes INCB28050, a Phase IIb clinical trial product for rheumatoid arthritis; INCB28060, a Phase I/II product for solid tumors; INCB7839, a Phase II product for breast cancer; and INCB24360, a Phase I/II product for solid tumors. It has a collaborative research and license agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; and Pfizer Inc. The company was founded in 1991 and is headquartered in Wilmington, Delaware.

Advisors' Opinion:

• [By Jay Silverman]

  Steve Halpern: One of your long-standing recommendations is Incyte (INCY), which recently reported some positive news and saw a huge jump in the price-up close to 30% in one day. What happened there and what's your outlook for the stock?

• [By Paul Ausick]

  Big earnings winners: Incyte Corp. (NASDAQ: INCY) up 34.4% to $36.02 on a successful drug trial, Target Corp. (NYSE: TGT) down 3.5% to $65.54 on weak earnings and lowered outlook, and Lowe�� Companies Inc. (NYSE: LOW ) up 4.4% at $46.01 on strong earnings and an improved outlook.

• [By Ben Levisohn]

  Sure Intercept Pharmaceuticals (ICPT) might feel like the only biotech stock that matters today, but there are others. For instance, Incyte (INCY) and� BioMarin (BMRN) are on the move after Barclays changed its ratings on the pair.